Gama Paul Insider Trades & Stock Holdings

CEO- Health Care · The Procter & Gamble Company · Latest filing Oct 5, 2026

Gama Paul, CEO- Health Care at The Procter & Gamble Company has 1 Form 4 trade on file since Oct 5, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($323.38K), net -$323.38K. Latest filing: disposed of 2.23K shares of $PG on Oct 5, 2026 at $145.34.

Trades on file: 1
Open-market bought: $0
Open-market sold: $323.38K
Net open-market: -$323.38K
Latest filing: Oct 5, 2026

All insider trades by Gama Paul

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 5, 2026	$PG	Sell (Open-market sale)	2.23K	$145.34	$323.38K			+5.0%			CEO- Health Care		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Gama Paul traded

Frequently asked questions

Has Gama Paul been buying or selling stock?

Gama Paul has 0 open-market purchases and 1 open-market sale on file, net -$323.38K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Gama Paul's latest insider trade?

disposed of 2.23K shares of $PG on Oct 5, 2026 at $145.34.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text